Literature DB >> 26170964

Effect of thyroid hormone replacement therapy on cognition in long-term survivors of aneurysmal subarachnoid hemorrhage.

Jun Ma1, Xinjian Yang2, Hao Yin3, Yang Wang2, Hongbin Chen3, Chuangxi Liu3, Guoqiang Han3, Fangyou Gao3.   

Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) is a recently identified risk factor for chronic hypothyroidism. Patients with hypothyroidism often exhibit cognitive dysfunction. The aim of the present study was to determine the effects of thyroid hormone replacement therapy on cognition in aSAH survivors with hypothyroidism. A study population of 135 patients was recruited and subjected to the Montreal Cognitive Assessment (MoCA) and Beck Depression Inventory. Among the study population, 52 patients exhibited cognitive dysfunction. Thyroid hormone levels were measured in these patients using an electrochemiluminescence immunoassay in order to elucidate possible deficits in the thyrotrophic hormonal axes, and hypothyroidism was confirmed in 31 patients. Among these 31 patients, 22 patients consented to be randomized into groups and were administered levothyroxine replacement or a placebo treatment for 3 months. The MoCA and Wechsler Adult Intelligence Scale-Chinese version (WAIS-RC) testing were performed prior to and following the replacement therapy or placebo treatments. All subjects completed the study with no negative side effects. After 8-12 weeks of oral levothyroxine administration, it was observed that the serum concentration of thyroid-stimulating hormone was restored to normal levels. Furthermore, neuropsychological test results improved following the replacement therapy. A significant improvement was observed in the MoCA scores of the replacement group following therapy, with the exception of the score for abstraction. Additionally, significant improvements in the WAIS-RC were observed in the replacement group, with the exceptions of the information comprehension and letter-number sequencing scores. Thus, the present study has demonstrated the partial normalization of cognitive impairments in patients with hypothyroidism following aSAH as a result of appropriate levothyroxine replacement therapy.

Entities:  

Keywords:  Beck Depression Inventory; Montreal Cognitive Assessment; Wechsler Adult Intelligence Scale; aneurysmal; hypothyroidism; subarachnoid hemorrhage

Year:  2015        PMID: 26170964      PMCID: PMC4487046          DOI: 10.3892/etm.2015.2475

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  18 in total

1.  The influence of thyroid function on cognition in a sample of ethnically diverse, rural-dwelling women: a project FRONTIER study.

Authors:  Leigh A Johnson; Valerie Hobson; Marjorie Jenkins; Andrew Dentino; R Michael Ragain; Sid O'Bryant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

2.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

3.  Neuroendocrine dysfunction in patients recovering from subarachnoid hemorrhage.

Authors:  Vladimir Jovanovic; Sandra Pekic; Marko Stojanovic; Goran Tasic; Branko Djurovic; Ivan Soldatovic; Mirjana Doknic; Dragana Miljic; Marina Djurovic; Milica Medic-Stojanoska; Vera Popovic
Journal:  Hormones (Athens)       Date:  2010 Jul-Sep       Impact factor: 2.885

Review 4.  Management of subarachnoid haemorrhage.

Authors:  T A Kopitnik; D S Samson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

Review 5.  Hypopituitarism--a late consequence of aneurysmal subarachnoid haemorrhage?

Authors:  C J Gardner; M Javadpour; C Morgan; C Daousi; I A Macfarlane; D J Cuthbertson
Journal:  Br J Neurosurg       Date:  2011-02-28       Impact factor: 1.596

6.  High incidence of neuroendocrine dysfunction in long-term survivors of aneurysmal subarachnoid hemorrhage.

Authors:  Ioanna Dimopoulou; Andreas T Kouyialis; Marinella Tzanella; Apostolos Armaganidis; Nikolaos Thalassinos; Damianos E Sakas; Stylianos Tsagarakis
Journal:  Stroke       Date:  2004-10-21       Impact factor: 7.914

Review 7.  Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage.

Authors:  Gabriel J E Rinkel; Ale Algra
Journal:  Lancet Neurol       Date:  2011-04       Impact factor: 44.182

8.  Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.

Authors:  C M Fisher; J P Kistler; J M Davis
Journal:  Neurosurgery       Date:  1980-01       Impact factor: 4.654

9.  High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: a prospective investigation of anterior pituitary function in the acute phase and 12 months after the event.

Authors:  Fatih Tanriverdi; Ahmet Turan Dagli; Zuleyha Karaca; Kursad Unluhizarci; Ahmet Selcuklu; Felipe F Casanueva; Fahrettin Kelestimur
Journal:  Clin Endocrinol (Oxf)       Date:  2007-07-30       Impact factor: 3.478

10.  Which neuropsychological deficits are hidden behind a good outcome (Glasgow = I) after aneurysmal subarachnoid hemorrhage?

Authors:  B O Hütter; J M Gilsbach
Journal:  Neurosurgery       Date:  1993-12       Impact factor: 4.654

View more
  2 in total

1.  Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients.

Authors:  Adomas Bunevicius; Vytenis Pranas Deltuva; Sarunas Tamasauskas; Timothy Smith; Edward R Laws; Robertas Bunevicius; Giorgio Iervasi; Arimantas Tamasauskas
Journal:  Oncotarget       Date:  2017-01-31

2.  The burden of headache following aneurysmal subarachnoid hemorrhage: a prospective single-center cross-sectional analysis.

Authors:  Torge Huckhagel; Regine Klinger; Nils Ole Schmidt; Jan Regelsberger; Manfred Westphal; Patrick Czorlich
Journal:  Acta Neurochir (Wien)       Date:  2020-02-04       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.